Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jorg Sievers"'
Autor:
Haroon Arshad, Juan Carlos López Alfonso, Raimo Franke, Katina Michaelis, Leonardo Araujo, Aamna Habib, Yuliya Zboromyrska, Eva Lücke, Emilia Strungaru, Manas K. Akmatov, Haralampos Hatzikirou, Michael Meyer-Hermann, Astrid Petersmann, Matthias Nauck, Mark Brönstrup, Ursula Bilitewski, Laurent Abel, Jorg Sievers, Jordi Vila, Thomas Illig, Jens Schreiber, Frank Pessler
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-18 (2019)
Abstract Background There continues to be a great need for better biomarkers and host-directed treatment targets for community-acquired pneumonia (CAP). Alterations in phospholipid metabolism may constitute a source of small molecule biomarkers for a
Externí odkaz:
https://doaj.org/article/3d9601556c6342fabedbc34fda639d5e
Autor:
Mark Underwood, Rimgaile Urbaityte, Ruolan Wang, Joe Horton, James Oyee, Brian Wynne, Dainielle Fox, Bryn Jones, Choy Man, Jörg Sievers
Publikováno v:
Viruses, Vol 16, Iss 3, p 405 (2024)
In GEMINI-1/-2, dolutegravir + lamivudine was non-inferior to dolutegravir + tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in achieving viral suppression (viral load [VL] < 50 copies/mL) in treatment-naive adults. Abbott’s RealTime HIV-1 as
Externí odkaz:
https://doaj.org/article/edca285dec8249a08d43920bf573ff75
Autor:
Mounir Ait-Khaled, Juan Sierra Madero, Vicente Estrada, Roberto Gulminetti, Debbie Hagins, Hung-Chin Tsai, Choy Man, Jörg Sievers, Richard Grove, Andrew Zolopa, Brian Wynne, Jean van Wyk
Publikováno v:
HIV Research & Clinical Practice, Vol 23, Iss 1, Pp 9-14 (2021)
Background: GEMINI-1 and GEMINI-2 (ClinicalTrials.gov, NCT02831673 and NCT02831764, respectively) are double-blind, multicenter, phase III studies that demonstrated the non-inferiority of once-daily dolutegravir + lamivudine to dolutegravir + tenofov
Externí odkaz:
https://doaj.org/article/5ba59213feaa4f1abb8a36a2726d56ec
Autor:
Norma Porteiro, Pedro Cahn, Juan Sierra Madero, Choy Y. Man, Jörg Sievers, Rimgaile Urbaityte, Andrés Maldonado, Inez Prudente Martinez, Jean van Wykd Jaime Andrade-villanueva
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 26, Iss , Pp 102125- (2022)
Introdução: GEMINI-1/-2 demonstrou que dolutegravir (DTG) + lamivudina (3TC) foi não-inferior a DTG + tenofovir disoproxil fumarato/emtricitabina (TDF/FTC) em 48, 96 e 144 semanas em adultos virgens de tratamento. O objetivo desta análise foi exa
Externí odkaz:
https://doaj.org/article/e5ea422c770d4cc58e12bd82052272bb
Autor:
Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Jörg Sievers, Choy Man, Rimgaile Urbaityte, Mark Underwood, Jean Andre Van Wyk, Kimberly Smith, Roberto Zajdenverg
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 25, Iss , Pp 101259- (2021)
Externí odkaz:
https://doaj.org/article/0365528103eb4ff09e9ea73e308cd9f0